Opinion Instead of blindly reducing list prices for all drugs we should instead seek solutions that assess every treatment in the context of its value to individual patients and the downstream savings they may facilitate elsewhere. httpsbuff.ly32L5J

Opinion: Instead of blindly reducing list prices for all drugs, we should instead seek solutions that assess every treatment in the context of its value to individual patients and the downstream savings they may facilitate elsewhere. https://buff.ly/32L5J

23:00 EDT 18 Jul 2019 | STAT

Opinion: Instead of blindly reducing list prices for all drugs, we should instead seek solutions that assess every treatment in the context of its value to individual patients and the downstream savings they may facilitate elsewhere. https://buff.ly/32L5JPY 

More From BioPortfolio on "Opinion: Instead of blindly reducing list prices for all drugs, we should instead seek solutions that assess every treatment in the context of its value to individual patients and the downstream savings they may facilitate elsewhere. https://buff.ly/32L5J"